US Stock MarketDetailed Quotes

Revelation Biosciences (REVB)

Watchlist
  • 1.210
  • +0.080+7.08%
Close Apr 8 16:00 ET
  • 1.210
  • 0.0000.00%
Post 17:45 ET
4.50MMarket Cap-0.05P/E (TTM)

Revelation Biosciences (REVB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
54.86%-8.27M
47.51%-1.97M
82.84%-1.59M
22.57%-1.92M
1.53%-2.79M
-151.45%-18.32M
-87.12%-3.75M
-439.24%-9.26M
-24.46%-2.48M
-80.17%-2.84M
Net income from continuing operations
40.73%-8.91M
-45.50%-2.51M
14.92%-1.91M
70.86%-2.44M
23.51%-2.05M
-12,405.64%-15.04M
21.66%-1.73M
14.72%-2.24M
-479.34%-8.39M
-143.54%-2.68M
Operating gains losses
111.11%9.05K
96.60%-87
275.40%10.6K
99.03%-43
97.93%-1.42K
99.02%-81.44K
96.25%-2.56K
93.47%-6.04K
98.96%-4.42K
99.12%-68.43K
Depreciation and amortization
-3.10%27.06K
-18.96%5.85K
-6.30%6.77K
0.00%7.22K
15.31%7.22K
11.47%27.92K
15.31%7.22K
15.30%7.22K
15.30%7.22K
-0.02%6.26K
Other non cash items
-25.48%18.63K
----
----
--0
--6.72K
--25K
--0
--0
----
----
Change In working capital
99.82%-6.04K
107.12%149.45K
104.35%306.76K
-91.16%517.05K
-674.37%-979.3K
-448.53%-3.42M
-1,013.02%-2.1M
-829.76%-7.05M
3,247.47%5.85M
-355.37%-126.47K
-Change in prepaid assets
-347.88%-44.6K
-75.29%12.64K
686.56%62.12K
169.10%37.22K
-1,321.78%-156.57K
255.65%17.99K
-24.72%51.15K
-91.89%7.9K
-165.39%-53.87K
104.94%12.82K
-Change in payables and accrued expense
101.81%63.64K
107.53%161.89K
103.47%244.65K
-91.87%479.83K
-291.01%-822.73K
-485.27%-3.51M
-1,624.50%-2.15M
-912.48%-7.06M
2,301.11%5.91M
-223.53%-210.41K
-Change in other current assets
---30.94K
----
----
----
----
--0
----
----
----
----
-Change in other current liabilities
--5.87K
----
----
----
----
--0
----
----
----
----
-Change in other working capital
----
----
----
----
----
-13.33%71.13K
--0
--0
--0
16.32%71.13K
Cash from discontinued investing activities
Operating cash flow
54.86%-8.27M
47.51%-1.97M
82.84%-1.59M
22.57%-1.92M
1.53%-2.79M
-151.45%-18.32M
-87.12%-3.75M
-439.24%-9.26M
-24.46%-2.48M
-80.17%-2.84M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
-19.17K
17.69K
-17.69K
0
-19.17K
Net PPE purchase and sale
--0
--0
--0
--0
--0
---19.17K
--17.69K
---17.69K
--0
---19.17K
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
---19.17K
--17.69K
---17.69K
--0
---19.17K
Financing cash flow
Cash flow from continuing financing activities
-2.93%12.47M
-101.12%-41.17K
143.77%9.12M
3.39M
0
-8.39%12.85M
3.69M
3.74M
0
-61.37%5.42M
Net common stock issuance
-37.45%3.39M
--0
--0
--3.39M
--0
-61.39%5.42M
--0
--0
--0
-61.39%5.42M
Net preferred stock issuance
----
----
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
22.23%9.08M
-101.12%-41.17K
143.77%9.12M
--297
--0
21,854,932.35%7.43M
--3.69M
--3.74M
--0
568.42%127
Cash from discontinued financing activities
Financing cash flow
-2.93%12.47M
-101.12%-41.17K
143.77%9.12M
--3.39M
--0
-8.39%12.85M
--3.69M
--3.74M
--0
-61.37%5.42M
Net cash flow
Beginning cash position
-45.80%6.5M
94.29%12.71M
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
128.28%11.99M
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
128.28%11.99M
Current changes in cash
176.49%4.2M
-4,677.46%-2.01M
236.20%7.53M
159.28%1.47M
-209.15%-2.79M
-181.51%-5.49M
97.90%-42.03K
-222.25%-5.53M
-24.46%-2.48M
-79.44%2.56M
End cash Position
64.65%10.7M
64.65%10.7M
94.29%12.71M
-57.15%5.17M
-74.54%3.7M
-45.80%6.5M
-45.80%6.5M
-53.26%6.54M
-23.16%12.07M
-17.80%14.55M
Free cash flow
54.91%-8.27M
47.26%-1.97M
82.87%-1.59M
22.57%-1.92M
2.20%-2.79M
-151.71%-18.34M
-86.23%-3.73M
-440.27%-9.27M
-24.46%-2.48M
-81.39%-2.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 54.86%-8.27M47.51%-1.97M82.84%-1.59M22.57%-1.92M1.53%-2.79M-151.45%-18.32M-87.12%-3.75M-439.24%-9.26M-24.46%-2.48M-80.17%-2.84M
Net income from continuing operations 40.73%-8.91M-45.50%-2.51M14.92%-1.91M70.86%-2.44M23.51%-2.05M-12,405.64%-15.04M21.66%-1.73M14.72%-2.24M-479.34%-8.39M-143.54%-2.68M
Operating gains losses 111.11%9.05K96.60%-87275.40%10.6K99.03%-4397.93%-1.42K99.02%-81.44K96.25%-2.56K93.47%-6.04K98.96%-4.42K99.12%-68.43K
Depreciation and amortization -3.10%27.06K-18.96%5.85K-6.30%6.77K0.00%7.22K15.31%7.22K11.47%27.92K15.31%7.22K15.30%7.22K15.30%7.22K-0.02%6.26K
Other non cash items -25.48%18.63K----------0--6.72K--25K--0--0--------
Change In working capital 99.82%-6.04K107.12%149.45K104.35%306.76K-91.16%517.05K-674.37%-979.3K-448.53%-3.42M-1,013.02%-2.1M-829.76%-7.05M3,247.47%5.85M-355.37%-126.47K
-Change in prepaid assets -347.88%-44.6K-75.29%12.64K686.56%62.12K169.10%37.22K-1,321.78%-156.57K255.65%17.99K-24.72%51.15K-91.89%7.9K-165.39%-53.87K104.94%12.82K
-Change in payables and accrued expense 101.81%63.64K107.53%161.89K103.47%244.65K-91.87%479.83K-291.01%-822.73K-485.27%-3.51M-1,624.50%-2.15M-912.48%-7.06M2,301.11%5.91M-223.53%-210.41K
-Change in other current assets ---30.94K------------------0----------------
-Change in other current liabilities --5.87K------------------0----------------
-Change in other working capital ---------------------13.33%71.13K--0--0--016.32%71.13K
Cash from discontinued investing activities
Operating cash flow 54.86%-8.27M47.51%-1.97M82.84%-1.59M22.57%-1.92M1.53%-2.79M-151.45%-18.32M-87.12%-3.75M-439.24%-9.26M-24.46%-2.48M-80.17%-2.84M
Investing cash flow
Cash flow from continuing investing activities 00000-19.17K17.69K-17.69K0-19.17K
Net PPE purchase and sale --0--0--0--0--0---19.17K--17.69K---17.69K--0---19.17K
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0---19.17K--17.69K---17.69K--0---19.17K
Financing cash flow
Cash flow from continuing financing activities -2.93%12.47M-101.12%-41.17K143.77%9.12M3.39M0-8.39%12.85M3.69M3.74M0-61.37%5.42M
Net common stock issuance -37.45%3.39M--0--0--3.39M--0-61.39%5.42M--0--0--0-61.39%5.42M
Net preferred stock issuance ----------------------0--0--0--0--0
Proceeds from stock option exercised by employees 22.23%9.08M-101.12%-41.17K143.77%9.12M--297--021,854,932.35%7.43M--3.69M--3.74M--0568.42%127
Cash from discontinued financing activities
Financing cash flow -2.93%12.47M-101.12%-41.17K143.77%9.12M--3.39M--0-8.39%12.85M--3.69M--3.74M--0-61.37%5.42M
Net cash flow
Beginning cash position -45.80%6.5M94.29%12.71M-57.15%5.17M-74.54%3.7M-45.80%6.5M128.28%11.99M-53.26%6.54M-23.16%12.07M-17.80%14.55M128.28%11.99M
Current changes in cash 176.49%4.2M-4,677.46%-2.01M236.20%7.53M159.28%1.47M-209.15%-2.79M-181.51%-5.49M97.90%-42.03K-222.25%-5.53M-24.46%-2.48M-79.44%2.56M
End cash Position 64.65%10.7M64.65%10.7M94.29%12.71M-57.15%5.17M-74.54%3.7M-45.80%6.5M-45.80%6.5M-53.26%6.54M-23.16%12.07M-17.80%14.55M
Free cash flow 54.91%-8.27M47.26%-1.97M82.87%-1.59M22.57%-1.92M2.20%-2.79M-151.71%-18.34M-86.23%-3.73M-440.27%-9.27M-24.46%-2.48M-81.39%-2.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More